Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer

The New England Journal of Medicine
D S AlbertsB DuBeshter

Abstract

Intravenous platinum-based chemotherapy is the standard primary therapy for advanced ovarian cancer. We conducted a phase 3 trial to compare the effects of intraperitoneal and intravenous cisplatin on the survival of women with previously untreated, stage III, epithelial ovarian cancer. The patients underwent an initial exploratory laparotomy and resection of all tumor masses larger than 2 cm. Within four weeks after surgery, six courses of intravenous cyclophosphamide (600 mg per square meter of body-surface area per course) plus either intraperitoneal cisplatin (100 mg per square meter) or intravenous cisplatin (100 mg per square meter) were administered at three-week intervals. Of 654 randomized patients, 546 were eligible for the study. The estimated median survival was significantly longer in the group receiving intraperitoneal cisplatin (49 months; 95 percent confidence interval, 42 to 56) than in the group receiving intravenous cisplatin (41 months; 95 percent confidence interval, 34 to 47). The risk of death was lower in the intraperitoneal group than in the intravenous group (hazard ratio, 0.76; 95 percent confidence interval, 0.61 to 0.96; P = 0.02). Moderate-to-severe tinnitus, clinical hearing loss, and neuromuscula...Continue Reading

References

Apr 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S KirmaniS B Howell
Oct 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S B HowellR J Weiss
Oct 18, 1989·Journal of the National Cancer Institute·R GoelS B Howell
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G A OmuraR Mortel
Aug 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P NeijtJ B Vermorken
Dec 1, 1982·Annals of Internal Medicine·S B HowellM Green
Jan 1, 1995·CA: a Cancer Journal for Clinicians·P A WingoS Bolden

❮ Previous
Next ❯

Citations

Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·L A RundD M Kranz
Oct 3, 1999·Seminars in Surgical Oncology·V E Herrin, J T Thigpen
Mar 10, 2010·Cancer Chemotherapy and Pharmacology·Moon Ki ChoiWon Ki Kang
Jan 15, 2013·Cancer Chemotherapy and Pharmacology·Hidenori TamegaiTadatoshi Takayama
Jun 29, 2004·European Radiology·Franco OrsiMassimo Bellomi
May 15, 2012·Surgical Endoscopy·Wiebke SolaßMarc A Reymond
Jul 9, 2011·Investigational New Drugs·Paul ZarogoulidisKostantinos Zarogoulidis
Apr 21, 2007·Pharmaceutical Research·Max TsaiJessie L-S Au
Mar 4, 2010·Pharmaceutical Research·Gaurav Bajaj, Yoon Yeo
Jun 12, 2002·Current Treatment Options in Oncology·C F Verschraegen
Jan 4, 2008·Current Treatment Options in Oncology·Thomas LoweLucille Leong
Apr 22, 2009·Current Treatment Options in Oncology·Ernest S HanMark Wakabayashi
Feb 2, 2002·Current Oncology Reports·Prema P Peethambaram, Harry J Long
Oct 3, 2003·Current Oncology Reports·Gregory Friberg, Gini Fleming
Oct 17, 2006·Current Oncology Reports·Robert L Coleman, Anil K Sood
Dec 21, 2000·Current Oncology Reports·N Lambrou, E L Trimble
Sep 6, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Santiago González-Moreno
May 26, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A Poveda VelascoUNKNOWN GEICO Group
Jul 27, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A González Martín
Nov 3, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F C Muñoz-CasaresA Gómez-Portilla
Nov 18, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Francisco C Muñoz-CasaresJordi Muntané
Jun 11, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Antonio González-MartínLuis Chiva
Mar 8, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A González MartínA Poveda Velasco
Sep 3, 2013·Indian Journal of Surgical Oncology·Rajshekhar C JakaK R Ashwin
Jan 9, 2001·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M S YenC C Yuan
Aug 29, 2003·The Journal of Surgical Research·Faheez MohamedPaul H Sugarbaker
May 1, 1997·Lancet·H M Pinedo, G Giaccone
Sep 19, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·M F Flessner, R L Dedrick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Deborah K ArmstrongGynecologic Oncology Group
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M Markman, Joan L Walker
International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
M S YenC C Yuan
© 2021 Meta ULC. All rights reserved